| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10019798 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10006499 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10059337 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10060312 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10060313 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS44014764 | HTLV-1 | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TAT |
|---|---|
| DrugBank ID | DB00135 |
| Drug Name | Tyrosine |
| Target ID | BE0000692 |
| UniProt ID | P17735 |
| Regulation Type | |
| PubMed IDs | 17389761 |
| Citations | Dong S, Kang S, Gu TL, Kardar S, Fu H, Lonial S, Khoury HJ, Khuri F, Chen J: 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood. 2007 Jul 1;110(1):360-9. Epub 2007 Mar 27. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | Tyrosine and derivatives |
| SMILES | N[C@@H](CC1=CC=C(O)C=C1)C(O)=O |
| Pathways | Dopamine beta-Hydroxylase Deficiency; Tyrosine Metabolism; Thyroid Hormone Synthesis; Disulfiram Action Pathway; Aromatic L-Aminoacid Decarboxylase Deficiency; Monoamine Oxidase-A Deficiency (MAO-A); Catecholamine Biosynthesis; Phenylketonuria; Tyrosinemia, Transient, of the Newborn; Tyrosinemia Type 3 (TYRO3); Hawkinsinuria; Tyrosinemia Type 2 (or Richner-Hanhart Syndrome); Phenylalanine and Tyrosine Metabolism; Tyrosinemia Type I; Alkaptonuria; Tyrosine Hydroxylase Deficiency |
| PharmGKB | PA451822 |
| ChEMBL | CHEMBL925 |
